M
Minervax
0 followers
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Org chart
Per Fischer
Collapse
Bjørn Kantsø
CTO, Head of CMC
Karina Nymark
Vice President Clinical Operations
Tina Biehl
Vice President Bioanalysis & Analytical Quality
Anders Fink V.
Interim Chief Financial Officer, Consulting Role
Tal Zaks
Non Executive Director
Teams
Offices
- Something went wrong loading the org chart, please refresh the page.